Exponent, Inc. (NASDAQ:EXPO - Get Free Report)'s stock price reached a new 52-week low on Monday . The company traded as low as $71.29 and last traded at $71.34, with a volume of 229468 shares traded. The stock had previously closed at $72.51.
Exponent Stock Performance
The stock has a market capitalization of $3.62 billion, a PE ratio of 34.80 and a beta of 0.90. The stock's 50-day moving average price is $76.26 and its two-hundred day moving average price is $81.47.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.04. The firm had revenue of $137.44 million for the quarter, compared to analysts' expectations of $134.63 million. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The business's quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.59 EPS. On average, analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were issued a $0.30 dividend. The ex-dividend date was Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a yield of 1.68%. Exponent's dividend payout ratio is presently 58.54%.
Insiders Place Their Bets
In other Exponent news, VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP John Pye sold 2,000 shares of Exponent stock in a transaction dated Friday, May 23rd. The shares were sold at an average price of $76.32, for a total value of $152,640.00. Following the completion of the transaction, the vice president directly owned 29,204 shares of the company's stock, valued at approximately $2,228,849.28. This represents a 6.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,267 shares of company stock worth $489,120. Corporate insiders own 1.60% of the company's stock.
Institutional Trading of Exponent
A number of large investors have recently made changes to their positions in EXPO. Norges Bank purchased a new position in shares of Exponent during the fourth quarter worth approximately $52,381,000. Resona Asset Management Co. Ltd. purchased a new position in shares of Exponent during the fourth quarter worth approximately $38,538,000. Millennium Management LLC grew its position in shares of Exponent by 543.1% during the first quarter. Millennium Management LLC now owns 305,230 shares of the business services provider's stock worth $24,742,000 after acquiring an additional 257,766 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new position in shares of Exponent during the first quarter worth approximately $15,349,000. Finally, Geneva Capital Management LLC grew its position in shares of Exponent by 11.2% during the first quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider's stock worth $141,517,000 after acquiring an additional 176,152 shares during the last quarter. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
Exponent Company Profile
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.